Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Teams Up With Synthes To Develop and Commercialize Bone Healing Therapies

This article was originally published in The Pink Sheet Daily

Executive Summary

Drug-device company development collaborations are common, but the range, commercial nature and expected duration of the Synthes/Lilly deal is unusual.
Advertisement

Related Content

Stryker Bets $316 Million It Can Invigorate Orthovita's Biologics Biz
J&J Doubles Down On Orthopedics With Synthes Deal; Takes Lead In Trauma
J&J Doubles Down On Orthopedics With Synthes Deal; Takes Lead In Trauma

Topics

Advertisement
UsernamePublicRestriction

Register

PS072488

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel